DHS 145.10 (1) All persons with infectious tuberculosis or suspected tuberculosis, and their contacts, shall exercise all reasonable precautions to prevent the infection of others, under the using the applicable methods of control set out in section 9 under tuberculosis, pages 565 to 572, listed in the 18th edition (2004) of Control of Communicable Diseases Manual, edited by David L. Heymann, published by the official reports of the American Public Health Association, unless specified otherwise by the state epidemiologist.
Note: The handbook official report of the American Public Health Association entitled Control of Communicable Diseases Manual, 18th 20th edition (2004) (2015), edited by David L. Heymann, is on file in the Department’s Division of Public Health and the Legislative Reference Bureau, and is available for purchase from the American Public Health Association, Publications Sales, PO Box 933019, Atlanta, GA 31193-3019.
DHS 145.10 (3) Note: The official statements of the American Thoracic Society may be found in the Centers for Disease Control and Prevention’s recommendations and report “Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.” The report may be found in the Morbidity and Mortality Weekly Report, June 9, 2000, Vol. 49, No. RR-6. The official statements of the American Thoracic Society’s “Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children” Society, entitled “Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis” may be found in the American Journal of Respiratory and Critical Care Medicine Clinical Infectious Diseases, vol. 149 63, 1994 2016, pp. 1359-1374 e147-e195. These reports are on file in the Legislative Reference Bureau, and are available from the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701-2659.
SECTION 6. DHS 145.12 (2) (Note), (4) (b) 2. (Note), and (4) (b) 3. (Note) are amended to read:
DHS 145.12 (2) Note: “High-risk groups” are defined in the Centers for Disease Control and Prevention report, “Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.” entitled “Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection – United States, 2010.” The report may be found in the Morbidity and Mortality Weekly Report, Morbidity and Mortality Weekly Report, June 9 25, 2000 2010, Vol 49 vol. 59, No. RR-65, and is on file in the Legislative Reference Bureau, and is available from the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701–2659.
DHS 145.12 (4) (b) 2. Note: The official statement of the National Tuberculosis Controllers Association entitled “Tuberculosis Nursing: a Comprehensive Guide to Patient Care Tuberculosis Nursing: a Comprehensive Guide to Patient Care” is on file in the Legislative Reference Bureau, and is available from the National Tuberculosis Controllers Association, 2951 Flowers Road South, Suite 102, Atlanta, GA 30341-5533. 2452 Spring Rd, SE, Smyrna, GA 30080-3838.
DHS 145.12 (4) (b) 3. Note: The official statements of the American Thoracic Society entitled “Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.” may be found in the Centers for Disease Control and Prevention’s recommendations and report “Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.” The report may be found in the Morbidity and Mortality Weekly Report Morbidity and Mortality Weekly Report, June 9, 2000, Vol. 49, No. RR-6. The official statement of the American Thoracic Society’s “Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children Society, entitled “Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis” may be found in the American Journal of Respiratory and Critical Care Medicine Clinical Infectious Diseases, vol. 149 63, 1994 2016, pp. 1359-1374 e147-e195. The official statement of the American Thoracic Society’s Society entitled “Diagnostic Standards and Classification of Tuberculosis in Adults and Children” may be found in American Journal of Respiratory and Critical Care Medicine, vol. 161, 2000, pp.1376-1395. These reports are on file in the Legislative Reference Bureau, and are available from the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701-2659.
SECTION 7. DHS 145.13 (1) (a) (Note) is amended to read:
DHS 145.13 (1) (a) Note: “High-risk persons” are defined in the Centers for Disease Control and Prevention report, “Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection.” entitled “Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection – United States, 2010.” The report may be found in the Morbidity and Mortality Weekly Report Morbidity and Mortality Weekly Report, June 9 25, 2000 2010, Vol vol. 49 59, No. RR-6 5, and is on file in the Legislative Reference Bureau, and is available from the Department’s Division of Public Health, P.O. Box 2659, Madison, WI 53701–2659.
SECTION 8. DHS 145.22 and (Note) are amended to read:
DHS 145.22 Treatment guidelines. Nationally recognized guidelines, including the “Sexually Transmitted Diseases Treatment Guidelines, 2006” published by the U.S. Department of Health and Human Services, The official statements of the Centers for Disease Control and Prevention shall be considered in the treatment of sexually transmitted diseases unless otherwise specified by the state epidemiologist. Specific medical treatment shall be prescribed by a physician or advanced practice nurse prescriber.
Note: The publication, official statements of the Centers for Disease Control and Prevention entitled “Sexually Transmitted Diseases Treatment Guidelines, 2006 2015,” is on file in the Department’s Division of Public Health and the Legislative Reference Bureau, and may be purchased from the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402-9325. Telephone: (202) 512-1800. found in the Morbidity and Mortality Weekly Report, June 5, 2015, vol. 64, RR-3.
SECTION 9. DHS 145 Appendix A is repealed and recreated to read:
APPENDIX A
(See PDF for image)
Communicable Diseases and Other Notifiable Conditions
CATEGORY I:
The following diseases are of urgent public health importance and shall be reported IMMEDIATELY by telephone to the patient’s local health officer or to the local health officer’s designee upon identification of a case or suspected case. In addition to the immediate report, complete and fax, mail or electronically report an Acute and Communicable Diseases Case Report (DHS F-44151) to the address on the form, or enter the data into the Wisconsin Electronic Disease Surveillance System, within 24 hours. Public health intervention is expected as indicated. See s. DHS 145.04 (3) (a). Anthrax1,4,5
Botulism (Clostridium botulinum) (including foodborne, infant, wound, and other)1,2,4,5
Carbapenem-resistent Enterobacteriaceae (CRE)2
Cholera (Vibrio cholera)1,3,4
Diphtheria (Corynebacterium diphtheria)1,3,4,5
Haemophilus influenzae invasive disease, (including epiglottitis)1,2,3,5
Hantavirus infection1,2,4
Hepatitis A1,2,3,4,5
Measles (rubeola)1,2,3,4,5
Meningococcal disease (Neisseria meningitidis)1,2,3,4,5
Middle Eastern Respiratory Syndrome-associated Coronavirus (MERS-CoV)2,3,4
Pertussis (whooping cough, caused by any Bordetella infection)1,2,3,4,5
Plague (Yersinia pestis)1,4,5
Poliovirus infection (paralytic or nonparalytic)1,4,5
Primary Amebic Meningoencephalitis (PAM) (Naegleria fowleri)2,4,5,6
Rabies (human, animal)1,4,5
Ricin toxin4,5
Rubella1,2,4,5
Rubella (congenital syndrome)1,2,5
Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)1,2,3,4
Smallpox4,5
Tuberculosis1,2,3,4,5
Vancomycin-intermediate Staphylococcus aureus (VISA) and Vancomycin-resistant Staphylococcus aureus (VRSA) infection1,4,5
Viral Hemorrhagic Fever (VHF) (including Crimean-Congo, Ebola, Lassa, Lujo, and Marburg viruses, and New World Arenaviruses)1,2,3,4
Yellow fever1,4
Outbreaks, confirmed or suspected:
Foodborne or waterborne1, 3,4,6
Occupationally-related diseases6
Other acute illnesses3,4,6
Any detection of or illness caused by an agent that is foreign, exotic or unusual to Wisconsin, and that has public health implications4
CATEGORY II:
The following diseases shall be reported by fax, mail, or electronic reporting to the patient’s local health officer or to the local health officer’s designee on an Acute and Communicable Disease Case Report (DHS F-44151) or by other means or by entering the data into the Wisconsin Electronic Disease Surveillance System within 72 hours of the identification of a case or suspected case. See s. DHS 145.04 (3) (b). Anaplasmosis1,2,5
Arboviral disease (including, but not limited to, disease caused by California serogroup, Chikungunya, Dengue, Eastern Equine Encephalitis, Powassan, St. Louis Encephalitis, West Nile, Western Equine Encephalitis, and Zika viruses)1,2,4
Babesiosis 1,2,4,5
Blastomycosis2
Borreliosis (other than Lyme disease which is reportable as a distinct disease)2,4,6
Brucellosis1,2,4
Campylobacteriosis (Campylobacter infection) 1,2,3,4
Chancroid (Haemophilus ducreyi)1,2
Chlamydia trachomatis infection1,2,4,5
Coccidioidomycosis (Valley Fever)1,2,4
Cryptosporidiosis (Cryptosporidium infection)1,2,3,4
Cyclosporiasis (Cyclospora infection)1,2
Ehrlichiosis1,2,5
Environmental and occupational lung diseases:
